(Aoi N ° Xiv/2024-2025) Vaccines for Human Use for the Years 2024-2025
The submission deadline for this tender has passed.
Tender Summary
The PHARMACIE CENTRALE DE TUNISIE in Tunisia from African region had released this tender for Tenders are invited for (Aoi N ° Xiv/2024-2025) Vaccines for Human Use for the Years 2024-2025
Deadline for Receipt of Tenders: 12/07/2023
Date for Bid Opening: 12/07/2023
Lot No 1: 1vaccin Intended for the Prevention of Invasive Infections at Haemophilus Influenzae Type Bprp Conjugate of the Polyoside of Heamophilus Influenzae Type B Stabilized10 Μg (Hib Polyoside)/ Dosebte/ 1 Fl/ 1 Dose2,000 Btes2 000
Provisional Deposit: 1
Lot No 2: 2*Vaccine Intended for the Prevention of Fluvaccin Containing at Least 3 Strains of Influenza Virus to be Determined According to the Recommendations of Who: 2 Type a and 1 Type B15 Μg of Hemaglutinin/Strain/Dosebte/1 Ser- -Ramly or Fl/ 1 Dose560,000 Btes560,000
Provisional Deposit: 1
Lot No 3: 3vaccin Anti-Meringococcal Conjugue a C W135 Y (Also Indicated in Subjects Aged 55 and over) Conjugated Vaccine Containing the 4 Polyosides of Neisseria Meningitidis Serogroups a, C, W135 and Y at Least 5 Μg/Serogroup/Dose Bte/1fl-Amp/ 1 Diluting or Pre -Filled Syringe /1 Dose70,00070,000
Provisional Deposit: 1
Lot No 4: 4vaccin Injectable Intended for the Prevention of Poliomyelitevirus Poliomyelitiques: Type1, Type 2 and Type 3polio Type 1 Inactivated Cast/ Dose Type 2 Inactivated ≥8ud/ Dose Type 3 Inactivated ≥32 Ud/ Dose Bte/ 1 Fl or Filled/ 1 Dose500 Btes500
Provisional Deposit: 1
Lot No 5: 5vaccin Intended for the Prevention of Diphtery and Tetanos (Recall Vaccine) Indicated for the Vaccination of Children from 6 Years Old and Adults including the Pregnant Woman Purified Purified Diphteric Anatoxin Purified (Recall Vaccination) ³ 2 Ui/Dose (A .Diphteric) ³20 Iu/ Dose (A. Tetanique) Bte/ 1 Amp or Fl Ser/ 1 Dose200,000 Btes200 000
Provisional Deposit: 1
Lot No 6: 6vaccin Recombinant Intended for the Prevention of Hepatitis B (Pediatric Use) Vaccine Produced by the Recombinant Dna Technique10 Μg of Hbs Antigen / Dose (Validated Technique Compared to the in Vivo Trial) Bte / 1 Fl / 1 Dose 45,000 Btes45,000
Provisional Deposit: 1
Lot No 7: 7vaccin Recombinant Intended for the Prevention of Hepatitis B (Adult Use) Vaccine Produced by the Technique of Recombinant Dna20 Μg of Hbs Antigen/ Dose (Technique Validated Compared to the in Vivo Trial) Bte/ 1 Fl/ 1 Dose 70,000 Btes70,000
Provisional Deposit: 1
Lot No 8: 8vaccin Intended for the Prevention of Hepatitis a (Pediatric Use) Hepatitis Virus Inactivated Adsorbed Relative Activity ³ 1 (European Pharmacopoeia Technique 4 Eme Edition 2.7.14 /According to the Recommendations of the Oms) / 1 Fl Ser or Ser-Pre-Remplie / 1 Pediatric Dose45,000 Btes45,000
Provisional Deposit: 1
Lot No 9: 9vaccin Intended for the Prevention of Hepatitis a (Adult Use) Hepatitis Virus a Inactivated Adsorbed Relative Activity ³ 1 (European Pharmacopoeia Technique 4 Eme Edition 2.7.14 /According to the Recommendations of the Whos) Unit Bte / 1 Fl Ser or Ser-Pre-Remplie/ 1 Adult Dose1 500 Btes1 500
Provisional Deposit: 1
Lot No 10: 10vaccin Combined Hexavalent Intended for the Prevention of Diphtery, Tetanos, Acellular Darling, Hepatitis B, Poliomyelitis and Invasive Infections in Haemophilus Influenzae Type Bvaccin Combined Hexavalent "Anatoxine Diphteric and Anatoxine Dose Tetanical /Antiguene Dose of Bordetella Pertassis -10µg of Hbs Antigen/Prp Dose Conjugate of the Polyoside of Haemophilus Influenzae Type B Stabilized 10 Μg Inactivated Polio Virus Type 1 (Mahoney), Type 2 and Type 3 (Saukett) "Bte/1 Fl Lyophilisat Ser Pre-Filled or Pre-Filled/1dose 48,000 Btes 48,000
Provisional Deposit: 1
Lot No 11: 11vaccin Intended for the Prevention of Diphtery and Tetanos (Primovacccination) Purified Diphteric Anatoxin - Purified Tetanical Anatoxin (Bivalent Adsorbed Vaccine for Primovaccination) ³ 30 Ui/Dose (A.Diphteric) ³ 40 Ui/Dose (A. Tétanique) Fl/ 10 Doses Vvm1,000 Fl10,000
Provisional Deposit: 1
Lot No 12: 12vaccin Intended for the Prevention of Diphtery and Tetanos (Recall Vaccine) Indicated for the Vaccination of Children from 6 Years Old and Adults including the Woman Pregnant for Purified Diphteric Purified Anatoxin Purified Tetanical (Recall Vaccination) ³ 2 Iu/Dose (A .Diphteric) ³20 Ui/Dose (A. Tetanique) Fl/10doses with 160,000 Fl1 600,000 -Pastille for Vaccine Control on each Bottle (V V M)
Provisional Deposit: 1
Lot No 13: 13vaccin Injectable Intended for the Prevention of Poliomyelitevirus Poliomelitiques: Type1, Type 2 and Type 3polio
Provisional Deposit: 1
Lot No 14:
Provisional Deposit: 1
Lot No 15:
Provisional Deposit: 1
Lot No 16:
Provisional Deposit: 1
Lot No 17:
Provisional Deposit: 1
Lot No 18:
Provisional Deposit: 1
Lot No 19:
Provisional Deposit: 1
Lot No 20:
Provisional Deposit: 1
[Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.] with tender notice no. XIV24-25 published on 30 May 2023. The tender expired on 12 Jul 2023. This tender is sourced from Official Website and is eligible for suppliers interested in Vaccines. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 3175221.
Tender Details
Tender NoticeTI Ref: 3175221
Tender Notice No
XIV24-25
Tender Organisation
PHARMACIE CENTRALE DE TUNISIE
Tender Sector
Tender Service
Worldwide
Tender Region
Tender Project Location
Tender CPV
33651600 : Vaccines
Tender Document Type
Tender Notice
Tender Deadline
12 Jul 2023 Deadline passed
Tender Description
Tenders are invited for (Aoi N ° Xiv/2024-2025) Vaccines for Human Use for the Years 2024-2025
Deadline for Receipt of Tenders: 12/07/2023
Date for Bid Opening: 12/07/2023
Lot No 1: 1vaccin Intended for the Prevention of Invasive Infections at Haemophilus Influenzae Type Bprp Conjugate of the Polyoside of Heamophilus Influenzae Type B Stabilized10 Μg (Hib Polyoside)/ Dosebte/ 1 Fl/ 1 Dose2,000 Btes2 000
Provisional Deposit: 1
Lot No 2: 2*Vaccine Intended for the Prevention of Fluvaccin Containing at Least 3 Strains of Influenza Virus to be Determined According to the Recommendations of Who: 2 Type a and 1 Type B15 Μg of Hemaglutinin/Strain/Dosebte/1 Ser- -Ramly or Fl/ 1 Dose560,000 Btes560,000
Provisional Deposit: 1
Lot No 3: 3vaccin Anti-Meringococcal Conjugue a C W135 Y (Also Indicated in Subjects Aged 55 and over) Conjugated Vaccine Containing the 4 Polyosides of Neisseria Meningitidis Serogroups a, C, W135 and Y at Least 5 Μg/Serogroup/Dose Bte/1fl-Amp/ 1 Diluting or Pre -Filled Syringe /1 Dose70,00070,000
Provisional Deposit: 1
Lot No 4: 4vaccin Injectable Intended for the Prevention of Poliomyelitevirus Poliomyelitiques: Type1, Type 2 and Type 3polio Type 1 Inactivated Cast/ Dose Type 2 Inactivated ≥8ud/ Dose Type 3 Inactivated ≥32 Ud/ Dose Bte/ 1 Fl or Filled/ 1 Dose500 Btes500
Provisional Deposit: 1
Lot No 5: 5vaccin Intended for the Prevention of Diphtery and Tetanos (Recall Vaccine) Indicated for the Vaccination of Children from 6 Years Old and Adults including the Pregnant Woman Purified Purified Diphteric Anatoxin Purified (Recall Vaccination) ³ 2 Ui/Dose (A .Diphteric) ³20 Iu/ Dose (A. Tetanique) Bte/ 1 Amp or Fl Ser/ 1 Dose200,000 Btes200 000
Provisional Deposit: 1
Lot No 6: 6vaccin Recombinant Intended for the Prevention of Hepatitis B (Pediatric Use) Vaccine Produced by the Recombinant Dna Technique10 Μg of Hbs Antigen / Dose (Validated Technique Compared to the in Vivo Trial) Bte / 1 Fl / 1 Dose 45,000 Btes45,000
Provisional Deposit: 1
Lot No 7: 7vaccin Recombinant Intended for the Prevention of Hepatitis B (Adult Use) Vaccine Produced by the Technique of Recombinant Dna20 Μg of Hbs Antigen/ Dose (Technique Validated Compared to the in Vivo Trial) Bte/ 1 Fl/ 1 Dose 70,000 Btes70,000
Provisional Deposit: 1
Lot No 8: 8vaccin Intended for the Prevention of Hepatitis a (Pediatric Use) Hepatitis Virus Inactivated Adsorbed Relative Activity ³ 1 (European Pharmacopoeia Technique 4 Eme Edition 2.7.14 /According to the Recommendations of the Oms) / 1 Fl Ser or Ser-Pre-Remplie / 1 Pediatric Dose45,000 Btes45,000
Provisional Deposit: 1
Lot No 9: 9vaccin Intended for the Prevention of Hepatitis a (Adult Use) Hepatitis Virus a Inactivated Adsorbed Relative Activity ³ 1 (European Pharmacopoeia Technique 4 Eme Edition 2.7.14 /According to the Recommendations of the Whos) Unit Bte / 1 Fl Ser or Ser-Pre-Remplie/ 1 Adult Dose1 500 Btes1 500
Provisional Deposit: 1
Lot No 10: 10vaccin Combined Hexavalent Intended for the Prevention of Diphtery, Tetanos, Acellular Darling, Hepatitis B, Poliomyelitis and Invasive Infections in Haemophilus Influenzae Type Bvaccin Combined Hexavalent "Anatoxine Diphteric and Anatoxine Dose Tetanical /Antiguene Dose of Bordetella Pertassis -10µg of Hbs Antigen/Prp Dose Conjugate of the Polyoside of Haemophilus Influenzae Type B Stabilized 10 Μg Inactivated Polio Virus Type 1 (Mahoney), Type 2 and Type 3 (Saukett) "Bte/1 Fl Lyophilisat Ser Pre-Filled or Pre-Filled/1dose 48,000 Btes 48,000
Provisional Deposit: 1
Lot No 11: 11vaccin Intended for the Prevention of Diphtery and Tetanos (Primovacccination) Purified Diphteric Anatoxin - Purified Tetanical Anatoxin (Bivalent Adsorbed Vaccine for Primovaccination) ³ 30 Ui/Dose (A.Diphteric) ³ 40 Ui/Dose (A. Tétanique) Fl/ 10 Doses Vvm1,000 Fl10,000
Provisional Deposit: 1
Lot No 12: 12vaccin Intended for the Prevention of Diphtery and Tetanos (Recall Vaccine) Indicated for the Vaccination of Children from 6 Years Old and Adults including the Woman Pregnant for Purified Diphteric Purified Anatoxin Purified Tetanical (Recall Vaccination) ³ 2 Iu/Dose (A .Diphteric) ³20 Ui/Dose (A. Tetanique) Fl/10doses with 160,000 Fl1 600,000 -Pastille for Vaccine Control on each Bottle (V V M)
Provisional Deposit: 1
Lot No 13: 13vaccin Injectable Intended for the Prevention of Poliomyelitevirus Poliomelitiques: Type1, Type 2 and Type 3polio
Provisional Deposit: 1
Lot No 14:
Provisional Deposit: 1
Lot No 15:
Provisional Deposit: 1
Lot No 16:
Provisional Deposit: 1
Lot No 17:
Provisional Deposit: 1
Lot No 18:
Provisional Deposit: 1
Lot No 19:
Provisional Deposit: 1
Lot No 20:
Provisional Deposit: 1
[Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.]
Tender Bidding Type
Tender Document
Frequently Asked Questions About This Tender
Who has issued this tender, and what is it for?
The tender has been issued by PHARMACIE CENTRALE DE TUNISIE in Tunisia. Such a type of tender falls under Vaccines, within the Healthcare & Medical sector, and is listed on Tender Impulse under notice number XIV24-25.
What are the key dates for this tender?
The notice was published on 30 May 2023 and submissions close on 12 Jul 2023. Late bids are rarely accepted in public procurement, so aim to have your documents ready several days before the closing date.
Which CPV codes apply to this tender?
It is classified under CPV codes 33651600, which correspond to Vaccines. If your company supplies these products or services, these are the codes to save in your alert profile so no matching tender passes you by.
Can I submit my bid for this tender to Tender Impulse?
No - and this matters. Tender Impulse is a tender aggregation and alert service: we collect procurement notices from official sources around the world and list them in one place. We do not receive, forward or evaluate bids. Your bid for this tender must be submitted directly to PHARMACIE CENTRALE DE TUNISIE, using the method described in the original tender document, before 12 Jul 2023. Tender Impulse provides complete assistance in submitting all bids posted on its website.
How do I get the bid documents and participation details?
Request a live demo on Tender Impulse and our tender experts will walk you through this listing, share the available documents, and explain how to submit your bid to PHARMACIE CENTRALE DE TUNISIE. Subscribers also receive help with registration requirements and, where needed, translation of non-English notices - but the submission itself always goes from you to the buyer.
How can I find more tenders like this in Tunisia?
There are currently 2881 live tenders of 47035 total tenders from Tunisia on Tender Impulse. You can browse them on our Tunisia tenders page, or save a search combining Tunisia with CPV codes 33651600 - we will then email you every new match on the day it is published.
How to prepare for this bid?
Suppliers must verify technical specifications, the delivery schedules and any other intrinsic details as provided in the complete bid documents before deciding to submit their bids. All necessary certifications and supplier registrations must be undertaken before participation.
Is this tender beneficial for me?
The procurement is applicable to companies in the Vaccines and related industries. If you belong to this industry, you can review the technical documents before assessing your relevance to your company.
What is the procurement trend for (Aoi N Xiv2024-2025) Vaccines for Human Use for the Years 2024-2025?
The public procurement trends for (Aoi N Xiv2024-2025) Vaccines for Human Use for the Years 2024-2025 can be assessed by viewing historical data and buying patterns for this product. Subscribed members can view and even download reports of tenders released in the past for their market research. This shall allow them to carefully prepare a compelling bid.
Explore More Vaccines Tenders in Tunisia, African Region and Worldwide
Looking for more tenders like this one in Vaccines? With millions of global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Healthcare & Medical sector in Tunisia, or expanding across regions, we provide live, accurate and relevant updates every day.
Our platform sources tenders from national and local government portals, international development and funding agencies, municipal corporations, state authorities, NGOs, education ministries and public-private partnerships.
Daily Tender Updates Across 190+ Countries
Every day we add hundreds of new RFPs, RFQs, EOIs and contract awards across multiple sectors and geographies. This tender from Tunisia is just a sample of what's available right now - there are currently 2,881 live Tunisia tenders to explore.
Search Smarter with CPV and Industry Matching
Each listing is categorised using CPV codes such as 33651600, enabling precise filtering by tender type, location, industry, deadline and issuing organisation.
Start Your Tender Journey
Request a free live demo to unlock tenders customised to your sector, country and CPV categories - with alerts, documents and submission support.
